Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Reported Tuberculosis in the United States, 2012

Return to Main Menu

(PDF - 179k)

Table 50. Culture-Positive Tuberculosis Cases and Percentages with Drug-Susceptibility Results, by Resistance to INH or Multidrug Resistance: Reporting Areas, 2012

Reporting AreaTotal Culture Positive CasesCases with Initial Drug-Susceptibility Testing Performed1 Resistance2
Isoniazid1 Isoniazid and Rifampin1
No.(%)No.(%)No.(%)

United States

7,598

7,250

(95.4)

660

(9.1)

83

(1.1)

Alabama

108

108

(100.0)

5

(4.6)

0

(0.0)

Alaska

50

50

(100.0)

1

(2.0)

0

(0.0)

Arizona

168

165

(98.2)

13

(7.9)

0

(0.0)

Arkansas

36

35

(97.2)

6

(17.1)

0

(0.0)

California

1,737

1,678

(96.6)

167

(10.0)

13

(0.8)

Colorado

47

47

(100.0)

3

(6.4)

1

(2.1)

Connecticut

55

53

(96.4)

7

(13.2)

1

(1.9)

Delaware

18

18

(100.0)

1

(5.6)

0

(0.0)

District of Columbia

28

27

(96.4)

1

(3.7)

0

(0.0)

Florida

539

497

(92.2)

40

(8.0)

6

(1.2)

Georgia

248

245

(98.8)

25

(10.2)

1

(0.4)

Hawaii

89

88

(98.9)

21

(23.9)

5

(5.7)

Idaho

10

10

(100.0)

3

(30.0)

0

(0.0)

Illinois

246

236

(95.9)

17

(7.2)

1

(0.4)

Indiana

78

77

(98.7)

8

(10.4)

0

(0.0)

Iowa

32

29

(90.6)

5

(17.2)

1

(3.4)

Kansas

40

40

(100.0)

0

(0.0)

0

(0.0)

Kentucky

60

59

(98.3)

6

(10.2)

0

(0.0)

Louisiana

122

105

(86.1)

2

(1.9)

0

(0.0)

Maine

14

14

(100.0)

0

(0.0)

0

(0.0)

Maryland

161

160

(99.4)

9

(5.6)

1

(0.6)

Massachusetts

153

151

(98.7)

13

(8.6)

2

(1.3)

Michigan

102

101

(99.0)

4

(4.0)

2

(2.0)

Minnesota

124

124

(100.0)

12

(9.7)

1

(0.8)

Mississippi

66

65

(98.5)

7

(10.8)

0

(0.0)

Missouri

89

40

(44.9)

--

--

--

--

Montana

4

4

(100.0)

1

(25.0)

0

(0.0)

Nebraska

14

14

(100.0)

0

(0.0)

0

(0.0)

Nevada

58

53

(91.4)

6

(11.3)

2

(3.8)

New Hampshire

8

5

(62.5)

--

--

--

--

New Jersey

227

226

(99.6)

19

(8.4)

4

(1.8)

New Mexico

38

38

(100.0)

1

(2.6)

0

(0.0)

New York State3

161

158

(98.1)

14

(8.9)

3

(1.9)

New York City

492

480

(97.6)

53

(11.0)

16

(3.3)

North Carolina

170

169

(99.4)

16

(9.5)

1

(0.6)

North Dakota

13

0

(0.0)

--

--

--

--

Ohio

106

105

(99.1)

5

(4.8)

0

(0.0)

Oklahoma

69

63

(91.3)

3

(4.8)

0

(0.0)

Oregon

49

49

(100.0)

5

(10.2)

1

(2.0)

Pennsylvania

188

178

(94.7)

15

(8.4)

2

(1.1)

Rhode Island

19

19

(100.0)

2

(10.5)

0

(0.0)

South Carolina

84

79

(94.0)

7

(8.9)

0

(0.0)

South Dakota

14

14

(100.0)

1

(7.1)

0

(0.0)

Tennessee

113

113

(100.0)

9

(8.0)

0

(0.0)

Texas

919

847

(92.2)

73

(8.6)

5

(0.6)

Utah

28

28

(100.0)

2

(7.1)

1

(3.6)

Vermont

3

3

(100.0)

1

(33.3)

0

(0.0)

Virginia

173

172

(99.4)

16

(9.3)

5

(2.9)

Washington

164

154

(93.9)

25

(16.2)

4

(2.6)

West Virginia

7

6

(85.7)

2

(33.3)

0

(0.0)

Wisconsin

54

48

(88.9)

4

(8.3)

2

(4.2)

Wyoming

3

3

(100.0)

0

(0.0)

0

(0.0)

American Samoa4

1

1

(100.0)

0

(0.0)

0

(0.0)

Fed. States of Micronesia4

57

40

(70.2)

--

--

--

--

Guam4

32

27

(84.4)

2

(7.4)

0

(0.0)

Marshall Islandsv

75

74

(98.7)

3

(4.1)

3

(4.1)

N. Mariana Islands4

15

14

(93.3)

1

(7.1)

0

(0.0)

Puerto Rico4

62

54

(87.1)

5

(9.3)

1

(1.9)

Republic of Palauv

3

0

(0.0)

--

--

--

--

U.S. Virgin Islands4

2

1

(50.0)

--

--

--

--

1 Patients tested to at least isoniazid and rifampin

2 Isolates may be resistant to other drugs.Overall U.S. percentage based on 52 reporting areas (50 states, New York City, and the District of Columbia). Counts and percentages shown only for reporting areas with information reported for ≥75% of cases.

3 Excludes New York City.

4 Not included in U.S. totals.

Note: Ellipses indicate data not available.

Top